IPCALAB2019-07-012019-09-30in-bse-fin:OneOperatingExpenses01Member IPCALAB2019-07-012019-09-30in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares IPCALAB 2019-04-01 2020-03-31 2019-10-24 INR Crores Half yearly Single segment Pharmaceuticals 2019-07-01 2019-09-30 Unaudited Consolidated 12839000000.00 148000000.00 12987000000.00 3938600000.00 928200000.00 -369500000.00 2320400000.00 42300000.00 496300000.00 3362700000.00 10719000000.00 2268000000.00 0.00 2268000000.00 334700000.00 -15800000.00 318900000.00 0.00 1949100000.00 0.00 0.00 0.00 -13700000.00 1935400000.00 -2000000.00 1933400000.00 1930700000.00 4700000.00 1928000000.00 5400000.00 252700000.00 2 15.32 15.32 0.00 0.00 15.32 15.32 0.00 0.00 0.00 1. The above financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on November 07, 2019.The Statutory Auditors have carried out the limited review of the results for the quarter ended Sept 30, 2019 only. The financial results and other financial information for the quarter and half year ended Sept 30, 2018 have not been subjected to limited review/audit. n nHowever, the management has exercised due diligence to ensure that such financial results provide a true and fair view of its affairs. n n2 The Board has allotted 5,00,000 convertible warrants to the members of Promoters / Promoter Group of the Company with a right to the warrant holders to apply for and be allotted 1 (one) equity share of Rs. 2/- each of the Company at a price of. Rs 955/- (including premium of Rs. 953/- per share), for each warrant, within a period of 18 months from the date of allotment of the said warrants. n n3 The Group has only one operating segment viz, 'Pharmaceuticals', n n4 Figures of the previous periods have been regrouped wherever necessary, 2019-04-01 2019-09-30 Unaudited Consolidated 23620900000.00 351400000.00 23972300000.00 7227700000.00 1776900000.00 -447300000.00 4477500000.00 88200000.00 957300000.00 5940300000.00 20020600000.00 3951700000.00 0.00 3951700000.00 709200000.00 -16800000.00 692400000.00 0.00 3259300000.00 0.00 0.00 0.00 -29600000.00 3229700000.00 -10700000.00 3219000000.00 3227000000.00 2700000.00 3213100000.00 5900000.00 252700000.00 2 25.56 25.56 0.00 0.00 25.56 25.56 0.00 0.00 0.00 other expenses 3362700000.00 other expenses 5940300000.00